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Preface to the special issue on amyloidogenic protein–membrane interactionAmyloids were discovered in human tissues by Virchow and
colleagues in 1854. The major components of amyloids are
fibrillar proteins. More than 20 diseases are known to
accompany the deposition of amyloids (amyloidosis). The
investigation of amyloidosis is a hot topic not only in the field of
medical sciences but also in protein chemistry and biophysics,
especially because amyloidosis includes severe neurodegener-
ative diseases. For example, Alzheimer's disease, the most
common form of dementia, is believed to be triggered by the
deposition of amyloid β-protein on neurons. Parkinson's
disease, Huntington's disease, and Creutzfeldt–Jakob disease
are related to the fibrillization of α-synuclein, polyglutamine,
and Prion protein, respectively.
The abnormal aggregation of these proteins is proposed to
occur by nucleation-dependent (or seeded) polymerization, in
which the formation of a nucleus (seed) is the rate-limiting step.
Several biological components, such as metal ions and other
proteins, are known to accelerate the nucleation. Accumulating
evidence suggests that membranes also play a pivotal role in the
amyloidogenesis of the neurodegenerative disease-related
proteins.0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.04.014This special issue collects 12 review articles on amyloido-
genic protein–membrane interaction by leading scientists in the
field. The first 5 articles focus on the methodology. Fluores-
cence, high-resolution NMR, solid-state NMR, infrared spec-
troscopy, and kinetics are be summarized by Munishkina and
Fink, Hoshino et al., Naito and Kawamura, Komatsu et al., and
Murphy, respectively. Specific topics on amyloid β-protein and
islet amyloid polypeptide are then reviewed by Matsuzaki,
Yanagisawa, Arispe et al., Lal et al., Smith et al., Zinser et al.,
and Jayasinghe and Langen. These papers cover physicochem-
ical, chemical, and biochemical aspects of amyloidogenic
protein–membrane interaction. I am confident that this special
issue will give valuable, cutting-edge information and stimu-
lating ideas to all scientists in this research area.
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